{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:51:59Z","timestamp":1776091919511,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.fitote.2025.106862","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:54:20Z","timestamp":1757375660000},"page":"106862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Shenling Jianpiwei formula ameliorates metabolic associated fatty liver disease through modulation of the gut microbiota and attenuation of LPS-mediated inflammation"],"prefix":"10.1016","volume":"186","author":[{"given":"Lyuzhen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2025.106862_bb0005","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fitote.2025.106862_bb0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2025.106862_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.08.027","article-title":"A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe","volume":"72","author":"Lazarus","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fitote.2025.106862_bb0025","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2025.106862_bb0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2025.106862_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.fitote.2025.106862_bb0045","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.fitote.2025.106862_bb0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut\u2013liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.fitote.2025.106862_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/ijms17040447","article-title":"Gut microbiota and lifestyle interventions in NAFLD","volume":"17","author":"Houghton","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2025.106862_bb0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.fitote.2025.106862_bb0065","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/nu11081712","article-title":"Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD)","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.fitote.2025.106862_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.fitote.2025.106862_bb0075","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.fitote.2025.106862_bb0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00535-014-0953-z","article-title":"The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications","volume":"49","author":"Goldsmith","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.fitote.2025.106862_bb0085","first-page":"628","article-title":"A review of studies on spleen deficiency syndrome based on intestinal microflora, modernization of Tradit","volume":"26","author":"Zhang","year":"2024","journal-title":"Chin. Med. Mater. Med. World Sci.Technol."},{"key":"10.1016\/j.fitote.2025.106862_bb0090","first-page":"98","article-title":"Exploring the mechanism of intestinal inflammation regulation by acupuncture in rats with spleen deficiency based on miRNA-29c-3p\/LIF axis","volume":"2","author":"Zhang","year":"2024","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0095","first-page":"272","article-title":"Effects of Xiangsha Liujunzi decoction on intestinal flora and its metabolite SCFAs in spleen-deficient IBS-D rats","volume":"46","author":"Zhang","year":"2024","journal-title":"Chin. Tradit. Pat. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1323261","article-title":"Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota","volume":"14","author":"Cai","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.fitote.2025.106862_bb0105","first-page":"2330","article-title":"Effect of Shenling Jianpiwei granules on UCP-2 and Cytb expression in liver of mice with nonalcoholic fatty liver disease","volume":"30","author":"Yao","year":"2019","journal-title":"Lishizhen Med. Mater. Med. Res."},{"key":"10.1016\/j.fitote.2025.106862_bb0110","first-page":"677","article-title":"Shenling Jianpiwei granules in treating 119 cases of children\u2019s diarrhea with spleen deficiency pattern: a multi- center, randomized, double-blind placebo-controlled trial","volume":"62","author":"Yan","year":"2021","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0115","first-page":"854","article-title":"Chinese archives of traditional chinese medicine Jianpiwei granules in treatment of irritable bowel syndrome with diarrhea","volume":"34","author":"Zhang","year":"2016","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0120","first-page":"18","article-title":"High cell density fermentation of Lactobacillus reuteri based on concentrated fed-batch technology","volume":"48","author":"Li","year":"2022","journal-title":"Food Ferment. Ind."},{"key":"10.1016\/j.fitote.2025.106862_bb0125","first-page":"139","article-title":"Effects of whey protein isolate fibrils and typical antioxidants on the survival of spray-dried Lactobacillus reuteri TMW 1.656 during ambient storage","volume":"44","author":"Guo","year":"2023","journal-title":"Food Sci."},{"key":"10.1016\/j.fitote.2025.106862_bb0130","doi-asserted-by":"crossref","first-page":"D795","DOI":"10.1093\/nar\/gkab786","article-title":"gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites","volume":"50","author":"Cheng","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fitote.2025.106862_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-0716-3060-0_14","article-title":"Analysis of adhesion and surface motility of a spirochete bacterium","volume":"2646","author":"Nakamura","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.fitote.2025.106862_bb0140","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.fitote.2025.106862_bb0145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.fitote.2025.106862_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105549","article-title":"Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology","volume":"146","author":"Zhang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.fitote.2025.106862_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.fitote.2025.106862_bb0160","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fitote.2025.106862_bb0165","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fmicb.2018.00757","article-title":"Role of Lactobacillus reuteri in human health and diseases","volume":"9","author":"Mu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fitote.2025.106862_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126038","article-title":"Fructus mori polysaccharide alleviates diabetic symptoms by regulating intestinal microbiota and intestinal barrier against TLR4\/NF-\u03baB pathway","volume":"249","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.fitote.2025.106862_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1966278","article-title":"Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader","volume":"13","author":"van Muijlwijk","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.fitote.2025.106862_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110240","article-title":"Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice","volume":"143","author":"Mu","year":"2021","journal-title":"Food Res. Int."},{"key":"10.1016\/j.fitote.2025.106862_bb0185","doi-asserted-by":"crossref","first-page":"12883","DOI":"10.1039\/D2FO03384D","article-title":"Structural elucidation and anti-nonalcoholic fatty liver disease activity of Polygonatum cyrtonema Hua polysaccharide","volume":"13","author":"Liu","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.fitote.2025.106862_bb0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41575-022-00581-2","article-title":"Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders","volume":"19","author":"Metwaly","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.fitote.2025.106862_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1863133","article-title":"The prebiotic effects of omega-3 fatty acid supplementation: a six-week randomised intervention trial","volume":"13","author":"Vijay","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.fitote.2025.106862_bb0200","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.fitote.2025.106862_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102196","article-title":"Targeting the gut microbiota-related metabolites for osteoporosis: the inextricable connection of gut-bone axis","volume":"94","author":"Zhang","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.fitote.2025.106862_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: diet, health and the gut microbiota","volume":"6","author":"Zmora","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.fitote.2025.106862_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.1254766","article-title":"Small molecules from the human microbiota","volume":"349","author":"Donia","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.fitote.2025.106862_bb0220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cmet.2023.12.013","article-title":"Serine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD","volume":"36","author":"Ghrayeb","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.fitote.2025.106862_bb0225","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1017\/S0954422421000202","article-title":"Carbohydrates deteriorate fatty liver by activating the inflammatory response","volume":"35","author":"Gao","year":"2022","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.fitote.2025.106862_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4161\/gmic.28403","article-title":"Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer","volume":"5","author":"Hintze","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.fitote.2025.106862_bb0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3164\/jcbn.14-74","article-title":"Bacterial cell wall components regulate adipokine secretion from visceral adipocytes","volume":"56","author":"Taira","year":"2015","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.fitote.2025.106862_bb0240","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-biophys-083012-130338","article-title":"Molecular basis of NF-\u03baB signaling","volume":"42","author":"Napetschnig","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.fitote.2025.106862_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1621583","article-title":"The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy","volume":"16","author":"Shen","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fitote.2025.106862_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.109885","article-title":"El-Nezami, alpha-aminobutyric acid ameliorates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression in mice via enhancing AMPK\/SIRT1 pathway and modulating the gut-liver axis","volume":"140","author":"Felicianna","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.fitote.2025.106862_bb0255","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01718-25","article-title":"Microbial biotherapeutic metabolite alleviates liver injury by restoring hepatic lipid metabolism through PPAR\u03b1 across the gut-liver axis","author":"Kramer","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.fitote.2025.106862_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1606669","article-title":"Gut microbiota regulates serum metabolites in mice with nonalcoholic fatty liver disease via gut metabolites: mechanisms involving branched-chain amino acids and unsaturated fatty acids","volume":"16","author":"Qiu","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.fitote.2025.106862_bb0265","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41401-020-00534-y","article-title":"Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo","volume":"42","author":"Ma","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.fitote.2025.106862_bb0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/21691401.2025.2475088","article-title":"The integration of metabolites from Forsythia suspensa and gut microbiota ameliorates drug-induced liver injury: network pharmacology and molecular docking studies","volume":"53","author":"Wang","year":"2025","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.fitote.2025.106862_bb0275","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21691401.2025.2547646","article-title":"Elucidating the integrative role and possible molecular mechanisms of salvia miltiorrhiza ingredients and gut microbiota-derived metabolites in alleviating pyroptosis-mediated hepatic ischemia\u2013reperfusion injury through network pharmacology","volume":"53","author":"Wang","year":"2025","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.fitote.2025.106862_bb0280","unstructured":"L\u00dc Y., Zheng W., Wang Q., Zhu J., Huang X., Cao Z., Luan X., Research progress of natural active substances against metabolic associated fatty liver disease, Acta Vet. Zootech. Sin. 56 (2025) 45\u201362. doi:10.11843\/j.issn.0366-6964.2025.01.005."},{"key":"10.1016\/j.fitote.2025.106862_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313163","article-title":"Neochlorogenic acid attenuates hepatic lipid accumulation and inflammation via regulating miR-34a in vitro","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2025.106862_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.958329","article-title":"The new exploration of pure total flavonoids extracted from Citrus maxima (Burm.) Merr. As a new therapeutic agent to bring health benefits for people","volume":"9","author":"Ding","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.fitote.2025.106862_bb0295","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1002\/tox.24295","article-title":"Glycyrrhizic acid attenuates the malignant biological properties of nonalcoholic fatty liver disease-related hepatocellular carcinoma","volume":"39","author":"Huang","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.fitote.2025.106862_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121110","article-title":"Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet","volume":"310","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.fitote.2025.106862_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155271","article-title":"Chlorogenic acid regulates the expression of NPC1L1 and HMGCR through PXR and SREBP2 signaling pathways and their interactions with HSP90 to maintain cholesterol homeostasis","volume":"123","author":"Meng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.fitote.2025.106862_bb0310","first-page":"1121","article-title":"Advances in research on chlorogenic acid","volume":"36","author":"Wang","year":"2017","journal-title":"J. Food Sci. Biotechnol."},{"key":"10.1016\/j.fitote.2025.106862_bb0315","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.3390\/ijms26135982","article-title":"Hesperidin is a promising nutraceutical compound in counteracting the progression of NAFLD in vitro","volume":"26","author":"Cofano","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fitote.2025.106862_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111110","article-title":"Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation","volume":"398","author":"He","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.fitote.2025.106862_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115304","article-title":"Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K\/AKT pathway","volume":"163","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X25004885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X25004885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T18:51:35Z","timestamp":1758999095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X25004885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":65,"alternative-id":["S0367326X25004885"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2025.106862","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shenling Jianpiwei formula ameliorates metabolic associated fatty liver disease through modulation of the gut microbiota and attenuation of LPS-mediated inflammation","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2025.106862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106862"}}